FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to compounds of formula I: and their pharmaceutically acceptable salts, in which R1-R4 have values, given in item 1 of invention formula. Said compounds possess inhibiting activity with respect to 11-beta-hydroxysteroid-dehydrogenase and can be applied for production of medications, intended for treatment and prevention of diabetes, especially, diabetes of II type, obesity, malnutrition and hypertension.
EFFECT: development of efficient method of obtaining formula I compounds and based on them pharmaceutical composition.
25 cl, 1 tbl, 149 ex
Title | Year | Author | Number |
---|---|---|---|
ALKYL-PYRIDAZINE DERIVATIVES AS INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1(11β-HSD 1) | 2007 |
|
RU2417989C2 |
PYRIDAZINE DERIVATIVES AS RORc MODULATORS | 2017 |
|
RU2757571C2 |
BICYCLIC PYRIDINE DERIVATIVES USEFUL AS FATTY ACID BINDING PROTEIN (FABP) 4 AND / OR 5 INHIBITOR | 2013 |
|
RU2648247C2 |
BORONIC ACID DERIVATIVES | 2018 |
|
RU2793315C2 |
PYRAZOLONE DERIVATIVES | 2006 |
|
RU2407737C2 |
4-HYDROXYBENZOPYRAN-2-ONE OR 4-HYDROXYCYCLOALKYL[B]BENZOPYRAN- -2-ONE AND, METHOD OF SYNTHESIS OF N-[3-[CYCLOPROPYL- -(5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-2-OXO-2H-CYCLOOCTA[B]- -PYRAN-3-YL)METHYL]PHENYL]-BENZENESULFONE | 1994 |
|
RU2125999C1 |
NEW LIGANDS OF CANNACBINOID RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHOD FOR PRODUCING THEREOF | 2006 |
|
RU2420518C2 |
SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR TREATING VESTIBULAR DISORDERS | 2009 |
|
RU2589846C2 |
0 |
|
SU476750A3 | |
NEW BICYCLIC COMPOUNDS OF THIOPHENYLAMIDE | 2013 |
|
RU2644565C2 |
Authors
Dates
2010-10-20—Published
2006-06-26—Filed